Cite
HARVARD Citation
Chun, B. et al. (2022). Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer. Journal for immunotherapy of cancer. 10 (1), p. . [Online].